Financial reports
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-K/A
2020 FY
Annual report (amended)
14 Jan 22
10-Q
2021 Q3
Quarterly report
16 Nov 21
NT 10-Q
Notice of late quarterly filing
16 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
29 Jun 21
NT 10-Q
Notice of late quarterly filing
18 May 21
Current reports
8-K
Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation
7 Oct 22
8-K
Lux Health Tech Acquisition Corp. Signs Letter of Intent for a Business Combination
6 Sep 22
8-K
Entry into a Material Definitive Agreement
25 Jul 22
8-K
Entry into a Material Definitive Agreement
3 Dec 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
16 Nov 21
8-K
Lux Health Tech Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
28 May 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
18 May 21
8-K
Other Events
11 Dec 20
8-K
Report of Independent Registered Public Accounting Firm
4 Nov 20
8-K
Lux Health Tech Acquisition Corp. Announces Pricing of $300 Million Initial Public Offering
30 Oct 20
Registration and prospectus
15-12G
Securities registration termination
8 Nov 22
25-NSE
Exchange delisting
28 Oct 22
424B4
Prospectus supplement with pricing info
28 Oct 20
8-A12B
Registration of securities on exchange
23 Oct 20
S-1/A
IPO registration (amended)
22 Oct 20
S-1
IPO registration
9 Oct 20
DRS
Draft registration statement
11 Sep 20
Other
UPLOAD
Letter from SEC
1 Sep 22
CORRESP
Correspondence with SEC
31 Aug 22
UPLOAD
Letter from SEC
12 Aug 22
EFFECT
Notice of effectiveness
27 Oct 20
CERT
Certification of approval for exchange listing
26 Oct 20
CORRESP
Correspondence with SEC
23 Oct 20
CORRESP
Correspondence with SEC
23 Oct 20
CORRESP
Correspondence with SEC
22 Oct 20
UPLOAD
Letter from SEC
21 Oct 20
CORRESP
Correspondence with SEC
9 Oct 20
Ownership
SC 13G/A
Lux Encore Sponsor, LP
19 Jan 23
SC 13G
Sculptor Capital LP
24 May 22
SC 13G/A
D1 Capital Partners L.P.
14 Feb 22
SC 13G
Weiss Asset Management LP
11 Feb 22
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
3 Feb 22
SC 13G/A
Wolfswood Holdings, LLC
4 Jun 21
SC 13G
D1 Capital Partners L.P.
16 Feb 21
SC 13G
MANULIFE FINANCIAL CORP
3 Feb 21
SC 13G
Lux Encore Sponsor, LP
29 Jan 21
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
25 Jan 21